Evidence map›Paper›PMID 9529323›Full record

ArticleThe Journal of experimental medicine1998

Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production.

K Ruckdeschel, S Harb, A Roggenkamp, M Hornef, R Zumbihl, S Köhler, J Heesemann, B Rouot

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 239 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Heightened Virulence ofInfection and immunity · 2021
    Article
  6. Article
  7. The role of nuclear factor kappa B (NF-κB) in filarial pathology.Journal of cell communication and signaling · 2021
    Review
  8. Review
  9. Frontiers in public health · 2020
    Article
  10. Article
  11. Outer Membrane Protein 25 ofFrontiers in veterinary science · 2017
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Subversion of inflammasome activation and pyroptosis by pathogenic bacteria.Frontiers in cellular and infection microbiology · 2013
    Review
  17. Article
  18. Article
  19. Article
  20. Cell death programs in Yersinia immunity and pathogenesis.Frontiers in cellular and infection microbiology · 2012
    Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

K RuckdeschelInstitut National de la Santé et de la Recherche Médicale U431, Université Montpellier II, 34095 Montpellier Cedex 05, France.
S Harb
A Roggenkamp
M Hornef
R Zumbihl
S Köhler
J Heesemann
B Rouot
Institute of Medical Microbiology and Hygiene · DEInserm · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we investigated the activity of transcription factor NF-kappaB in macrophages infected with Yersinia enterocolitica. Although triggering initially a weak NF-kappaB signal, Y. enterocolitica inhibited NF-kappaB activation in murine J774A.1 and peritoneal macrophages within 60 to 90 min. Simultaneously, Y. enterocolitica prevented prolonged degradation of the inhibitory proteins IkappaB-alpha and IkappaB-beta observed by treatment with lipopolysaccharide (LPS) or nonvirulent, plasmid-cured yersiniae. Analysis of different Y. enterocolitica mutants revealed a striking correlation between the abilities of these strains to inhibit NF-kappaB and to suppress the tumor necrosis factor alpha (TNF-alpha) production as well as to trigger macrophage apoptosis. When NF-kappaB activation was prevented by the proteasome inhibitor MG-132, nonvirulent yersiniae as well as LPS became able to trigger J774A.1 cell apoptosis and inhibition of the TNF-alpha secretion. Y. enterocolitica also impaired the activity of NF-kappaB in epithelial HeLa cells. Although neither Y. enterocolitica nor TNF-alpha could induce HeLa cell apoptosis alone, TNF-alpha provoked apoptosis when activation of NF-kappaB was inhibited by Yersinia infection or by the proteasome inhibitor MG-132. Together, these data demonstrate that Y. enterocolitica suppresses cellular activation of NF-kappaB, which inhibits TNF-alpha release and triggers apoptosis in macrophages. Our results also suggest that Yersinia infection confers susceptibility to programmed cell death to other cell types, provided that the appropriate death signal is delivered.

Indexed as

AnimalsApoptosisCell LineDNA-Binding ProteinsEnzyme InhibitorsFlavonoidsGene Expression RegulationHumansImidazolesLeupeptinsLipopolysaccharidesMacrophages, PeritonealMiceNF-kappa BPyridinesSerotyping2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-onebenzyloxycarbonylleucyl-leucyl-leucine aldehydeDNA-Binding ProteinsEnzyme InhibitorsFlavonoidsImidazolesLeupeptinsLipopolysaccharidesNF-kappa BPyridinesSB 203580Tumor Necrosis Factor-alpha

Identifiers

PMID9529323
PMCPMC2212204
OpenAlexW2114527805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.